A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinoma

Sorafenib, a multikinase inhibitor, is the first and only drug, which improves significantly the overall survival in patients with advanced hepatocellular carcinoma (HCC). However, many patients experience diverse side effects, some of them severe and unexpected. To date, acute acalculous cholecysti...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Aihara, Yosuke, Yoshiji, Hitoshi, Yamazaki, Masaharu, Ikenaka, Yasuhide, Noguchi, Ryuichi, Morioka, Chie, Kaji, Kosuke, Tastumi, Haruki, Nakanishi, Keisuke, Nakamura, Maiko, Yamao, Junichi, Toyohara, Masahisa, Mitoro, Akira, Sawai, Masayoshi, Yoshida, Motoyuki, Fujimoto, Masao, Uemura, Masahito, Fukui, Hiroshi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Co., Limited 2012
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3360105/
https://ncbi.nlm.nih.gov/pubmed/22645635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v4.i5.115
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller